What is the current ASND expected move?

As of Oct 14, 2026, Ascendis Pharma A/S (ASND) has an expected move of 13.25% over the next 37 days, implying a one-standard-deviation price range of $197.06 to $257.22 from the current $227.14. The expected move is derived from at-the-money straddle pricing and represents the market consensus for a ±1σ price move.

What does the ASND expected move mean for traders?

Roughly 68% of outcomes should fall within ±1 expected move and 95% within ±2 under lognormal assumptions, though equity returns have empirically fatter tails than log-normal predicts. Strategies sized to the expected move (iron condors at ±1σ, strangles at ±1.5σ) target the typical outcome distribution; strategies that profit from tail moves (long-vol structures, ratio backspreads) target the tails the lognormal model under-prices.

How is ASND expected move calculated?

The expected move displayed here is derived from at-the-money implied volatility scaled to the chosen tenor: expected move % is approximately ATM IV times sqrt(T / 365), where T is days to expiration. An equivalent straddle-based form: the ATM straddle (call + put at the same strike) is roughly sqrt(2/pi) times spot times IV times sqrt(T/365), so the implied one-standard-deviation move is approximately 1.25 times ATM straddle divided by spot. The two formulations agree once the sqrt(2/pi) constant is reconciled.

Ascendis Pharma A/S (ASND) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Ascendis Pharma A/S (ASND) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $13.86B, listed on NASDAQ, employing roughly 1,189 people, carrying a beta of 0.37 to the broader market. Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Led by Jan Moller Mikkelsen, public since 2015-01-28.

Snapshot as of Oct 14, 2026.

Spot Price: $227.14
Expected Move: 13.2%
Implied High: $257.22
Implied Low: $197.06
Front DTE: 37 days

As of Oct 14, 2026, Ascendis Pharma A/S (ASND) has an expected move of 13.25%, a one-standard-deviation implied price range of roughly $197.06 to $257.22 from the current $227.14. Expected move is derived from at-the-money straddle pricing and represents the market's pricing of a ±1σ move. Roughly 68% of outcomes should fall within this range under lognormal assumptions, though empirical markets have fatter tails.

ASND Strategy Sizing to the Expected Move

With Ascendis Pharma A/S pricing an expected move of 13.25% from $227.14, risk-defined strategies sized to the implied range structurally target the modal outcome distribution. Iron condors with wings at the ±1σ expected move boundaries collect premium against the ~68% probability that spot stays inside the range under lognormal assumptions; strangles set wider at ±1.5σ or ±2σ target the tails but pay smaller per-trade premium. Long-vol structures (long straddles, ratio backspreads) profit when realized move exceeds the implied move, the inverse trade: they bet against the lognormal assumption itself, capitalizing on the empirically fatter equity-return tails.

How to read the ASND implied-range chart

The shaded range below shows the one-standard-deviation implied price band at each listed expiration, derived from ATM implied volatility scaled to days-to-expiration. The front-tenor expected move is 13.25%, anchoring an implied range of approximately $197.06 to $257.22. Under lognormal assumptions, roughly 68% of outcomes fall inside that band; 95% fall inside ±2σ; 99.7% inside ±3σ. The empirical equity-return distribution has fatter tails than lognormal, so true tail-outcome frequency is moderately higher than these closed-form numbers suggest.

ASND expected move and event pricing

Expected move widens with √time: a 5% 30-day move corresponds to roughly a 2.5% 7.5-day move and a 10% 120-day move. ASND term-structure is in backwardation (slope -0.036), so near-dated tenors price in disproportionate vol - usually because of a known event in the front-month window. With IV rank at 3.6%, the implied move is at the low end of the typical ASND range - cheap optionality for buyers, thin premium for sellers.

Sizing ASND structures to the expected move

Iron condors with wings at ±1σ collect the modal-outcome premium; ±1.5σ widens probability of inside-range to ~87% but cuts collected premium roughly in half. Strangles do the inverse trade - they pay against the same lognormal distribution, profiting when realized exceeds implied. Calendar spreads bet on the slope of the term structure rather than the level. ASND put/call volume ratio currently at 0.88 indicates balanced flow without strong directional skew. The expected move is the inputs the chain is pricing, not a forecast - realized moves above or below are normal under any distribution.

Learn how expected move is reported and how to read the data →

Shaded band shows the ±1σ implied price range (~68% probability under lognormal assumptions) at each expiration; the center line marks current spot. Bands widen with longer DTE since volatility scales with √time.

Per-expiration expected move for ASND derived from ATM implied volatility at each listed expiration. Implied high/low bounds are computed as $227.14 × (1 ± expected move %). One standard-deviation range under lognormal assumptions, roughly 68% of outcomes fall inside.

Expiration	DTE	ATM IV	Expected Move	Implied High	Implied Low
Oct 16, 2026	2	34.9%	2.6%	$233.01	$221.27
Nov 20, 2026	37	46.2%	14.7%	$260.55	$193.73
Dec 18, 2026	65	42.6%	18.0%	$267.97	$186.31
Jan 15, 2027	93	43.1%	21.8%	$276.56	$177.72
Mar 19, 2027	156	43.1%	28.2%	$291.14	$163.14
Apr 16, 2027	184	42.4%	30.1%	$295.52	$158.76
Dec 17, 2027	429	40.0%	43.4%	$325.64	$128.64

Frequently asked ASND expected move questions

What is the current ASND expected move?: As of Oct 14, 2026, Ascendis Pharma A/S (ASND) has an expected move of 13.25% over the next 37 days, implying a one-standard-deviation price range of $197.06 to $257.22 from the current $227.14. The expected move is derived from at-the-money straddle pricing and represents the market consensus for a ±1σ price move.
What does the ASND expected move mean for traders?: Roughly 68% of outcomes should fall within ±1 expected move and 95% within ±2 under lognormal assumptions, though equity returns have empirically fatter tails than log-normal predicts. Strategies sized to the expected move (iron condors at ±1σ, strangles at ±1.5σ) target the typical outcome distribution; strategies that profit from tail moves (long-vol structures, ratio backspreads) target the tails the lognormal model under-prices.
How is ASND expected move calculated?: The expected move displayed here is derived from at-the-money implied volatility scaled to the chosen tenor: expected move % is approximately ATM IV times sqrt(T / 365), where T is days to expiration. An equivalent straddle-based form: the ATM straddle (call + put at the same strike) is roughly sqrt(2/pi) times spot times IV times sqrt(T/365), so the implied one-standard-deviation move is approximately 1.25 times ATM straddle divided by spot. The two formulations agree once the sqrt(2/pi) constant is reconciled.